Three Studies Support Medtronic’s Cryoablation Systems As ‘First Line’ AFib Treatment
Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.
You may also be interested in...
The series E financing will support the ongoing US trial of Adagio’s iCLAS cardiac cryoablation system and development of Adagio's pulsed field cryoablation technology while the company continues to commercialize iCLAS outside the US.
Fitbit will launch its new Fitbit Sense smartwatch with ECG app in Europe, US, Hong Kong and India in October.
Results from STOP AF showed intervention with Medtronic's cryoablation system is superior to medication as a “first-line” treatment for paroxysmal atrial fibrillation.